<DOC>
	<DOCNO>NCT02642068</DOCNO>
	<brief_summary>We anticipate drug-naïve ADHD probands , particularly DAT1 SLC6A2 gene variant may high level alter microstructural integrity frontostriatal ( FS ) , frontoparietal ( FP ) , hypothesize fiber tract decrease brain activity FS , FP , circuit , deficit ERP , impair EF , SA , IIA VM probands without DAT1 SLC6A2 gene variant adult neurotypical . The alteration structural functional connectivity , neurophysiological neuropsychological functioning would observe unaffected sibling compare neurotypical . The unaffected sibling intermediate position drug-naïve adult ADHD probands neurotypical . The genetic dosage anticipate pose strong effect cortical thickness , brain volume , gyrification microstructural property white matter , follow neurophysiology , functional connectivity , neuropsychological function least effect . In term longitudinal follow-up part , also anticipate despite increase thin cortical thickness , microstructural integrity several target fiber tract , brain activity target brain region improve performance EF , SA , IIV , VM childhood late adolescence young adulthood neurotypical group , slop developmental trajectory neuroimaging neuropsychological function lower ADHD group .</brief_summary>
	<brief_title>Neuropsychology , Neuroimage Neurophysiology Adults With ADHD</brief_title>
	<detailed_description>Attention deficit/hyperactivity disorder ( ADHD ) common ( 3-10 % ) , early-onset , clinically genetically heterogeneous neuropsychiatric disorder lifelong neuropsychological deficit . Despite extensive research adult ADHD western country , publish data adult ADHD Taiwan except PI 's colleague ' previous work pharmacotherapy adult ADHD endophenotype study base adult ADHD world . The ultimate goal 5-year project identify neuropsychological , functional structural connectivity , neurophysiological variable effective endophenotypes ( biomarkers ) ADHD base unaffected sibling ( 1st-3rd year ) follow-up ( 4th-5th year ) design . With accomplishment follow study goal , study first study topic neuroimaging neurophysiological endophenotypes adult ADHD use advanced imaging technique ( i.e. , Tract-based autonomic analysis , TBAA ) comprehensive clinical neurocognitive data . This proposal one primary aim four secondary aim : Primary Aim : 1 . To validate structural ( assessed TBAA use diffuse spectrum imaging , DSI ) functional connectivity ( assessed resting-state fMRI ) frontostriatal , frontoparietal circuitry , neurophysiological function ( assessed stop-signal event-related potential [ ERP ] : N2 , P3 , ERN , Pe ) effective image endophenotypes demonstrate intermediate position unaffected sibling ADHD probands , age- , sex- , handedness- , IQ-matched adult neurotypical association DAT1 NET ( SLC6A2 ) variant ; Secondary Aims : 2 . To validate executive function ( EF ) , sustain attention ( SA ) , intraindividual variability ( IIV ) , visual-spatial memory ( VM ) effective neurocognitive endophenotypes demonstrate intermediate position unaffected sibling ADHD probands , adult neurotypical ; 3 . To examine developmental trajectory stability neuropsychological function structural functional connectivity childhood adolescence young adulthood ; 4 . To correlate data structural ( morphometric , cortical thickness , gyrification , fiber tract integrity ) functional connectivity ( rsfMRI ) , neuropsychology ( Executive function , visual-spatial memory , sustain attention , variability ) , neurophysiology ( Stop-signal ERP ) ADHD core symptom stratify presence ADHD , presence DAT1 NET ( SLC6A2 ) variant , proband-unaffected sibling dyad , different developmental stage .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Subjects age 1630 , clinical diagnosis ADHD accord DSMIV DSM5 diagnostic criterion , never treat medication ADHD treatment . At least 30 60 subject samesex unaffected sibling . The subject exclude study meet follow criterion : ( 1 ) Comorbidity DSMIVTR DSM5 diagnose autism spectrum disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder , organic psychosis , schizotypal personality disorder , bipolar disorder , depression , severe anxiety disorder substance use ; ( 2 ) With neurodegenerative disorder , epilepsy , involuntary movement disorder , congenital metabolic disorder , brain tumor , history severe head trauma , history craniotomy ; ( 3 ) With visual hearing impairment , motor disability may influence process MRI assessment ; ( 4 ) Fullscale IQ low 80 .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Drug-naïve Adult ADHD</keyword>
	<keyword>Neuropsychology</keyword>
	<keyword>Neurophysiology</keyword>
	<keyword>Neuroimaging</keyword>
	<keyword>Follow-up</keyword>
</DOC>